Indirect Measurement of Left Ventricular Filling Pressure (LVFP) — CPB 0704 | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0704 covering indirect measurement of left ventricular filling pressure, effective November 26, 2025. CPT 0932T and HCPCS C9786 are both explicitly non-covered under this updated coverage policy.

Aetna's update to CPB 0704 draws a hard line on two technologies: the VeriCor® System for arterial waveform-based LVFP measurement and EchoGo Heart Failure for detecting heart failure with preserved ejection fraction (HFpEF). If your cardiology or heart failure program bills CPT 0932T or HCPCS C9786, those claims will not be reimbursed under Aetna plans. This isn't a gray area — both technologies are classified as experimental, investigational, or unproven across all indications.

Quick-Reference Table

Aetna LVFP Coverage Criteria and Medical Necessity Requirements 2025

The Aetna indirect LVFP coverage policy is straightforward: there is no covered indication for any of the technologies addressed in CPB 0704. Neither the VeriCor® System nor EchoGo Heart Failure meets Aetna's medical necessity threshold. The policy doesn't carve out exceptions for specific patient populations, severity levels, or clinical scenarios.

That's worth repeating plainly. There is no combination of ICD-10 diagnosis codes from the I50.x heart failure range that makes CPT 0932T or HCPCS C9786 billable to Aetna. Medical necessity documentation won't rescue these claims. The denial isn't a documentation problem — it's a coverage exclusion.

The EchoGo Heart Failure system uses AI-based post-processing of echocardiogram images to detect HFpEF. HCPCS C9786 is the code tied to this technology. Aetna's position is that the clinical evidence doesn't support coverage for HFpEF detection or any other indication. If your practice recently added AI-assisted echo analysis to its workflow, this policy applies to you.

The VeriCor® System measures LVFP indirectly by analyzing arterial waveform response to the Valsalva maneuver, then applies computerized calibration to produce a filling pressure estimate. CPT 0932T covers noninvasive heart failure detection derived from augmentative analysis of an echocardiogram. Both technologies sit in the same bucket under CPB 0704 — experimental, investigational, and unproven — regardless of how they're ordered or documented clinically.

There's no prior authorization pathway listed in this policy because prior authorization implies there's a route to approval. There isn't one here. Aetna isn't asking for more documentation or a peer-to-peer review. The coverage policy forecloses both codes entirely.

Aetna LVFP Exclusions and Non-Covered Indications

Aetna classifies both technologies under CPB 0704 as experimental or investigational because clinical evidence hasn't established their effectiveness. That's the standard Aetna uses across its Clinical Policy Bulletins when a technology hasn't cleared the bar for routine coverage.

For EchoGo Heart Failure specifically, the policy language is unusually broad. Aetna calls out "all other indications" after listing HFpEF detection. That means if a vendor or clinical team tries to justify HCPCS C9786 for a different use case — say, post-procedure assessment or risk stratification — Aetna's position is still non-covered. Don't test that interpretation with live claims.

The VeriCor® exclusion applies to the full category of indirect LVFP measurement via computerized calibration of arterial waveform response to the Valsalva maneuver. If a similar competing device uses the same mechanism, it almost certainly falls under the same exclusion even if it carries a different trade name. The policy targets the method, not just the brand.

This matters for practices that are piloting new cardiac monitoring tools or evaluating technology contracts. If a vendor is pitching you a device that measures LVFP indirectly through Valsalva maneuver analysis, CPB 0704 is the policy you'll be fighting at the payer level. Check the contract terms before you sign.

Coverage Indications at a Glance

Aetna LVFP Billing Guidelines and Action Items 2025

The effective date of November 26, 2025 has passed. If your team hasn't already addressed these codes in your charge capture and payer contract workflows, do it now.

CPT, HCPCS, and ICD-10 Codes for Indirect LVFP Measurement Under CPB 0704

Not Covered / Experimental CPT Codes

Not Covered / Experimental HCPCS Codes

Key ICD-10-CM Diagnosis Codes

These heart failure codes appear in the policy. None of them establish medical necessity for CPT 0932T or HCPCS C9786 under Aetna.

One note on the ICD-10 table: the policy lists all nine I50.x subcategory codes without differentiating by type (systolic, diastolic, acute, chronic). Aetna's non-coverage position applies across the entire heart failure diagnostic spectrum. No subcategory gets special treatment.